{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:15:15Z","timestamp":1774066515988,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bcmd.2019.102379","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T00:52:52Z","timestamp":1572742372000},"page":"102379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients"],"prefix":"10.1016","volume":"80","author":[{"given":"Marina","family":"Hovakimyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Ajay Narendra","family":"Talabattula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cozma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Beetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2019.102379_bb0005","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Fabry disease","author":"Mehta","year":"1993"},{"key":"10.1016\/j.bcmd.2019.102379_bb0010","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcmd.2019.102379_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2019.102379_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/diseases5020015","article-title":"Biomarkers and imaging findings of Anderson-Fabry disease-what we know now","volume":"5","author":"Beirao","year":"2017","journal-title":"Diseases"},{"key":"10.1016\/j.bcmd.2019.102379_bb0025","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2019.102379_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCGENETICS.113.000249","article-title":"Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease","volume":"7","author":"Niemann","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bcmd.2019.102379_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2012.08.055","article-title":"Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with Anderson-Fabry disease","volume":"111","author":"Coats","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bcmd.2019.102379_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002839","article-title":"High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in Fabry disease","volume":"5","author":"Seydelmann","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcmd.2019.102379_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","article-title":"Adiponectin: action, regulation and association to insulin sensitivity","volume":"6","author":"Lihn","year":"2005","journal-title":"Obes. Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.bcmd.2019.102379_bb0050","first-page":"428","article-title":"Adiponectin, an adipocyte-derived hepatic insulin sensitizer regulation during development","volume":"1","author":"Kim","year":"2004","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bcmd.2019.102379_bb0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0003319714523332","article-title":"Adiponectin as an independent predictor of left ventricular hypertrophy in nondiabetic patients with hypertension","volume":"66","author":"Peer","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.bcmd.2019.102379_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/AC.70.1.3064591","article-title":"Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk","volume":"70","author":"Chiara","year":"2015","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.bcmd.2019.102379_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1476-511X-13-120","article-title":"Increased Hs-CRP\/adiponectin ratio is associated with increase carotid intima-media thickness","volume":"13","author":"Liao","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bcmd.2019.102379_bb0070","doi-asserted-by":"crossref","first-page":"e001853","DOI":"10.1161\/JAHA.115.001853","article-title":"Sex-specific effects of adiponectin on carotid intima-media thickness and incident cardiovascular disease","volume":"4","author":"Persson","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcmd.2019.102379_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpeds.2015.04.044","article-title":"Association of adiponectin with adolescent cardiovascular health in a dietary intervention study","volume":"167","author":"Jaakkola","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2019.102379_bb0080","first-page":"1","article-title":"The emerging role of leptin, adiponectin and visfatin in ischemic\/hemorrhagic stroke","author":"Ilhan","year":"2019","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.bcmd.2019.102379_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1536\/ihj.13-287","article-title":"Association between adiponectin production in coronary circulation and future cardiovascular events in patients with coronary artery disease","volume":"55","author":"Kawagoe","year":"2014","journal-title":"Int. Heart J."},{"key":"10.1016\/j.bcmd.2019.102379_bb0090","doi-asserted-by":"crossref","first-page":"534320","DOI":"10.1155\/2015\/534320","article-title":"Differential role of leptin and adiponectin in cardiovascular system","volume":"2015","author":"Ghantous","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bcmd.2019.102379_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2015.11.067","article-title":"Relation of adiponectin to all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (from the Dallas Heart Study)","volume":"117","author":"Witberg","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bcmd.2019.102379_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5414\/CNP72021","article-title":"Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K\/DOQI 3 - 5 chronic kidney disease","volume":"72","author":"Nanayakkara","year":"2009","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bcmd.2019.102379_bb0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.bcmd.2019.102379_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mgg3.262","article-title":"A comprehensive global genotype-phenotype database for rare diseases","volume":"5","author":"Trujillano","year":"2017","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.bcmd.2019.102379_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/humu.22910","article-title":"Functional and clinical consequences of novel alpha-galactosidase a mutations in Fabry disease","volume":"37","author":"Lukas","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2019.102379_bb0120","first-page":"103","article-title":"Cardiac abnormalities in Fabry disease: natural history in hemizygote males suggests that cardiac pathology is universally present","volume":"8","author":"Altarescu","year":"2005","journal-title":"Haema"},{"key":"10.1016\/j.bcmd.2019.102379_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2019.102379_bb0130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.ki.5002191","article-title":"Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study","volume":"71","author":"Kollerits","year":"2007","journal-title":"Kidney Int."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619303791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619303791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:35:11Z","timestamp":1761050111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979619303791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":26,"alternative-id":["S1079979619303791"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102379","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102379"}}